Tamsulosin
Tascenso is a brand-name medication. Detailed information about its therapeutic uses, mechanism of action, and clinical indications is not specified in the available data. Consult prescribing information or a healthcare provider for complete details about this medication.
Tascenso is a brand-name medication; specific therapeutic information is not specified.
Key facts at a glance
- RxNorm
- 2610296
- Generic
- Tascenso
- Class
- brand-name
- Brands
- —
- Availability
- rx
- Lactation
- unknown
- Routes
- —
- Forms
- —
- Regions
- US, EU, CN, JP
- Monitoring
- —
This page is for informational purposes only.
Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.
Not specified
Not specified
As a brand-name medication, patients should consult their healthcare provider for complete prescribing information, including approved uses, contraindications, warnings, and potential side effects. Do not use without appropriate medical guidance.
Official drug label
WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 9, 2026. · Read our editorial policy